| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9921170 | European Journal of Pharmacology | 2005 | 4 Pages |
Abstract
It is concluded that the mGlu5 receptor antagonist MPEP potently inhibits transient lower esophageal sphincter relaxations and that the mGlu5 receptor is a potential target for treatment of gastroesophageal reflux disease.
Keywords
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Jörgen Jensen, Anders Lehmann, Anna Uvebrant, Anita Carlsson, Gunilla Jerndal, Karolina Nilsson, Claudine Frisby, L. Ashley Blackshaw, Jan P. Mattsson,